Healthcare -
Biotechnology - NASDAQ - US
$ 129.12
1.24 %
$ 6.3 B
Market Cap
-21.52
P/E
AXSM - CASH FROM OPERATIONS
Cash from Operations AXSM - Axsome Therapeutics, Inc.
-128 M
LAST VALUE
-4.98%
2 YEAR CAGR
-22.59%
5 YEAR CAGR
-39.51%
10 YEAR CAGR